Preferred Label : Abbott Architect SARS-CoV-2 QUANT II IgG Serology Assay;
NCIt definition : A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative
and quantitative determination of IgG antibodies to SARS-CoV-2 in human serum and
plasma on the Abbott ARCHITECT i system. It can be used to quantify IgG antibodies
against the spike receptor-binding domain (RBD) of SARS-CoV-2, which may correlate
with immune status.;
NCI Metathesaurus CUI : CL1663307;
Origin ID : C180708;
UMLS CUI : C5556573;
Semantic type(s)
- concept_is_in_subset
